You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AIDS-related diffuse large cell lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
Has Results
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
Jul 31, 2022

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse Trial run by the NCI (Rituximab, Filgrastim, EPOCH)

    Active, not recruiting
    Has Results
    • Lymphoma, AIDS-related
    • Lymphoma, Large B-Cell, Diffuse
    • Rituximab
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 21, 2022

    AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,

    Not yet recruiting
    • AIDS-Related Diffuse Large B-cell Lymphoma
    • +14 more
    • Axicabtagene Ciloleucel
    • +2 more
    • (no location specified)
    Feb 15, 2022

    AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States

    Completed
    Has Results
    • AIDS-Related Plasmablastic Lymphoma
    • +15 more
    • Montgomery, Alabama
    • +34 more
    Feb 23, 2022

    High-Dose Methotrexate Clearance in Diffuse Large B-Cell

    Recruiting
    • Central Nervous System Lymphoma
    • Diffuse Large B-Cell Lymphoma
    • Non-Interventional Study
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 8, 2023

    Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

    Recruiting
    • Diffuse Large B-cell Lymphoma Recurrent
    • Diffuse Large B Cell Lymphoma Refractory
    • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Oct 12, 2023

    Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-cell Lymphoma
    • RC19D2 cell injection
    • Tianjin, Tianjin, China
      Hematology Hospital of the Chinese Academy of Medical Sciences
    Sep 14, 2023

    Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
    • (no location specified)
    Sep 5, 2023

    Relapsed or Refractory Diffuse Large B-cell Lymphoma Trial in Beijing (BEBT-908 for injection)

    Active, not recruiting
    • Relapsed or Refractory Diffuse Large B-cell Lymphoma
    • BEBT-908 for injection
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Oct 8, 2023

    DLBCL Trial (Polatuzumab Vedotin)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • Polatuzumab Vedotin
    • (no location specified)
    Jul 12, 2023

    Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab vedotin and Rituximab)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Zanubrutinib, Polatuzumab vedotin and Rituximab
    • Shanghai, Shanghai, China
      Zhongshan Hospital，Fudan University
    Jul 10, 2023

    DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • Mitoxantrone Hydrochloride Liposome Injection
    • Jinan, Shandong, China
      Affiliated Cancer Hospital of Shandong First Medical University
    May 16, 2023

    Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Zanubrutinib, Polatuzumab Vedotin, Rituximab
    • Shanghai, Shanghai, China
      Zhongshan Hospital，Fudan University
    Jul 10, 2023

    Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • (no location specified)
    Mar 9, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

    Recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Lenalidomide combined with G-CHOP (LO CHOP)
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    DLBCL Trial (Acalabrutinib, Rituximab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • (no location specified)
    Jul 11, 2023

    Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +5 more
    • (no location specified)
    Nov 2, 2023

    Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • Measure of the circulating tumor DNA
    • Rouen, France
      Centre Henri Becquerel
    Nov 17, 2023

    Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

    Not yet recruiting
    • Lymphoma, B-Cell
    • +6 more
    • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
    • Guayaquil, Guayas, Ecuador
      Instituto Oncológico Nacional Dr. Juan Tanca Marengo
    Apr 27, 2023

    Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • Mitoxantrone hydrochloride liposome injection
    • +4 more
    • Changchun, Jilin, China
      The First Bethune Hospital of Jilin University
    Aug 15, 2023

    Selinexor Combined With Lenalidomide and Rituximab in Treatment

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • Selinexor combined with lenalidomide and rituximab
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jun 20, 2023

    Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • (no location specified)
    Mar 23, 2023